| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 47, 475-480, Copyright © 1988 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JW Suttie, LL Mummah-Schendel, DV Shah, BJ Lyle and JL Greger
Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison 53706.
Vitamin K is required for the maintenance of normal hemostatic function. Ten college-aged male subjects chose diets restricted in vitamin K content for 40 d. Median phylloquinone intakes based on analysis of food composites dropped from 82 micrograms/d during the prestudy period to 40 and 32 micrograms/d at d 9 and 27 of dietary restriction, respectively. Serum phylloquinone concentrations fell from a mean of 0.87 to 0.46 ng/mL during a 21-d period of vitamin K restriction. Supplementation with 50 micrograms phylloquinone/d for 12 d increased serum phylloquinone to 0.56 ng/mL, and supplementation with 500 micrograms phylloquinone/d increased serum phylloquinone to 1.66 ng/mL. Vitamin K restriction resulted in alterations in a functional clotting assay that detects undercarboxylated prothrombin species in plasma and in a decrease in urinary gamma-carboxyglutamic acid. Supplementation with either 50 or 500 micrograms of phylloquinone restored both these indices to near normal values. These data are consistent with a human dietary vitamin K requirement of approximately 1 microgram/kg body wt/d.
This article has been cited by other articles:
|
|
 |
|
  J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 160S - 198S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Lin Reviewing the reality: why we need to change Eur. Heart J. Suppl., June 1, 2005; 7(suppl_E): E15 - E20. [Full Text] [PDF]
|
|
|
|
|
|
J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson, and E. Hylek The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 204S - 233S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L Booth, I. Golly, J. M Sacheck, R. Roubenoff, G. E Dallal, K. Hamada, and J. B Blumberg Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status Am. J. Clinical Nutrition, July 1, 2004; 80(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Booth, L. Martini, J. W. Peterson, E. Saltzman, G. E. Dallal, and R. J. Wood Dietary Phylloquinone Depletion and Repletion in Older Women J. Nutr., August 1, 2003; 133(8): 2565 - 2569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hirsh, V. Fuster, J. Ansell, and J. L. Halperin American Heart Association/American College of Cardiology Foundation guide to warfarin therapy J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1633 - 1652. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hirsh, V. Fuster, J. Ansell, and J. L. Halperin American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy Circulation, April 1, 2003; 107(12): 1692 - 1711. [Full Text] [PDF]
|
|
|
|
|
|
J. Hirsh, J. E. Dalen, D. R. Anderson, L. Poller, H. Bussey, J. Ansell, and D. Deykin Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range Chest, January 1, 2001; 119(1_suppl): 8S - 21S. [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Couris, G. R. Tataronis, S. L. Booth, G. E. Dallal, J. B. Blumberg, and J. T. Dwyer Development of a Self-Assessment Instrument to Determine Daily Intake and Variability of Dietary Vitamin K J. Am. Coll. Nutr., June 1, 2000; 19(6): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L Booth, M. E O'Brien-Morse, G. E Dallal, K. W Davidson, and C. M Gundberg Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults Am. J. Clinical Nutrition, September 1, 1999; 70(3): 368 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Booth and J. W. Suttie Dietary Intake and Adequacy of Vitamin K1 J. Nutr., May 1, 1998; 128(5): 785 - 788. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Peters, K. D. Lawson, S. J. Middleton, and K. C. Triebwasser Assessment of the Nutritional Effects of Olestra, a Nonabsorbed Fat Replacement: Introduction and Overview J. Nutr., August 1, 1997; 127(8): 1539 - 1539. [Abstract] [Full Text]
|
|
|
|
|
|
B. P. Koonsvitsky, D. A. Berry, M. B. Jones, P. Y. T. Lin, D. A. Cooper, D. Y. Jones, and J. E. Jackson Olestra Affects Serum Concentrations of alpha -Tocopherol and Carotenoids but not Vitamin D or Vitamin K Status in Free-Living Subjects J. Nutr., August 1, 1997; 127(8): 1636 - 1636. [Abstract] [Full Text]
|
|
|
|
|
|
T. G. Schlagheck, K. A. Riccardi, N. L. Zorich, S. A. Torri, L. D. Dugan, and J. C. Peters Olestra Dose Response on Fat-Soluble and Water-Soluble Nutrients in Humans J. Nutr., August 1, 1997; 127(8): 1646 - 1646. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
